2[2]Smith JC.Potential sensitive molecular probes in membranes of bioenergetic relevance[J] .Biochim Biophys Acta, 1990, 106(1): 1.
3[3]Murphy MP.Selective targeting of bioactive compounds to mitochondria[J]. Trends Biotechnol, 1997, 15(8):326.
4[4]Manetta A, Gamboa G, Nasseri A, et al. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines[J] .GynecolOncol, 1996, 60(2): 203.
5[5]Smith RA, Porteous CM, Coulter CV, et al. Selective targeting of an antioxidant to mitochondria[J]. Eur J Biochem, 1999, 263(3): 709.
6[6]Lampidis TJ, Shi YF, Calderon CL, et al. Accumulation of simple organic cations correlates with differential cytotoxicity in multidrug-resistant and-sensitive human and rodent cells[J]. Leukemia, 1997, 11(7): 1 156.
7[7]Rizzuto R, Brini M, De Giorgi F, et al. Double labelling of subcellular structures with organelle-targeted GFP mutants in vivo[J]. Curr Biol, 1996, 6(2): 183.
8[8]Rizzuto R, Pinton P, Carrington W,et al. Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2 + responses[J]. Science, 1998, 280(5 370):1763.
9[9]Mueller GM, McKenzie LR, Homanics GE, et al. Complementation of defective leucine decarboxylation in fibroblasts from a maple syrup urine disease patient by retrovirus-mediated gene transfer[J]. Gene Ther, 1995,2(7) . 461.
10[10]Taylor RW, Chinnery PF, Turnbull DM, et al. Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids[J]. Nat Genet,1997, 15(2): 212.
同被引文献50
1MATI'SON MP. Pathways towards and away from Alzheimer's disease[J]. Nature, 2004, 430(7000): 631-639.
2CANEVARI L, ABRAMOV AY, DUCHEN MR. Toxicity of amyloid beta peptide: tales of calcium, mitochondria, and oxidative stress[J]. Neurochem Res, 2004, 29(3): 637-650.
3ROSSNER S, UEBERHAM U, SCHLIEBS R, et al. The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling[J]. Prog Neurobiol, 1998, 56(5): 541-569.
4DEMATTOS RB, CIRRITO JR, PARSADANIAN M, et al. ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo[J]. Neuron, 2004, 41 (2) : 193-202.
5SELKOE DJ. The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease[J]. Trends Cell Biol, 1998, 8( 11 ) : 447-453.
6GREENFIELD JP, TSAI J, GOURAS GK, et al. Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides[J]. Proc Natl Acad Sci USA. 1999, 96(2): 742-747.
7WILSON CA, DOMS RW, LEE VM. Intracellular APP processing and A beta production in Ahheimer disease[J]. J Neuropathol Exp Neurol, 1999, 58(8) : 787-794-.
8TENG FY, TANG BL. Widespread gamma-secretase activity in the cell, but do we need it at the mitochondria?[J]. Biochem Biophys Res Commun, 2005, 328( 1 ) : 1-5.
9WALSH DM, HARTLEY DM, KUSUMOTO Y, et cd. Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates[JI. J Biol Chem, 1999, 274(36):25945-25952.
10KLEIN WL, KRAFFT GA, FINCH CE. Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum? [J]. Trends Neurosci, 2001, 24(4) : 219-224.
